Post-chemotherapy neutropenic fever

ISBN-13: 9786206498988 / Angielski / Miękka / 52 str.

Juan Carlos De La Cruz Castillejos

Opis

There are currently no studies to support the use of Ceftazidime/amikacin-based regimen as first choice empirical treatment in patients with neutropenic fever.Demonstrate that the caftazidime/amikacin regimen is not the best empirical therapeutic approach, and could be directly impacting on longer recovery time, longer hospital stay, higher costs.

O autorze

Internist and rheumatologist from the National Autonomous University of Mexico.